Armel Nibasumba, BA (Biochemistry)
Armel was the first intern hosted at CHIL. Originally from Bujumbura, Burundi, he finished high school at Waterford Kamhlaba UWCSA in Swaziland. In May 2016, he completed his BA in Biochemistry and a double minor in Global Health and African studies at Middlebury College in Vermont, USA. At CHIL, he investigated the effect of Env peptide concentration on the stimulation of PBMC for the ICS assay. In the summer of 2015, he interned at the University of Washington Medical School in Dr. Tom Hawn’s lab, where he studied the influence of HDAC3 on TLR5 and NLRC4 in TB pathogenesis. Very passionate about science and global health, Armel hopes to leverage his scientific background and his public health interest to create solutions to healthcare problems in Africa. He is now working as a research technologist in Sarah Fortune’s lab at Harvard, studying TB.